This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top Research Reports for Johnson & Johnson, Intel and Procter & Gamble
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Intel (INTC) and Procter & Gamble (PG).
Why Is Procter & Gamble (PG) Down 9% Since its Last Earnings Report?
by Zacks Equity Research
Procter & Gamble (PG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Pick Procter & Gamble (PG) Stock Now?
by Zacks Equity Research
Let's see if The Procter & Gamble Company (PG) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Procter & Gamble (PG) Q2 Earnings & Revenues Top
by Zacks Equity Research
Procter & Gamble (PG) reported core earnings of $1.19 per share in Q2, beating the Zacks Consensus Estimate of $1.15/share.
How Procter & Gamble's (PG) Margins Will Shape Up in Q2
by Zacks Equity Research
Higher input cost, unfavorable mix and lower pricing in the shave care category likely hit Procter & Gamble's (PG) margins. However, the negatives might partly get offset by productivity savings.
Will New Products Lift Procter & Gamble's (PG) Q2 Sales?
by Zacks Equity Research
Soft consumer-spending environment and higher competition in developed markets might hurt Procter & Gamble's (PG) Q2 sales. However, new product launches are likely to offset the negatives.
Top Analyst Reports for Alphabet, Broadcom and Procter & Gamble
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Broadcom (AVGO) and Procter & Gamble (PG).
Factors to Weigh on Consumer Staples Stocks in 2018
by Zacks Equity Research
Responding to consumers' rapidly changing preferences creates significant competition, price wars and an intense promotional environment.
Clorox Hits 52-Week High: Will the Uptrend Continue in 2018?
by Zacks Equity Research
Clorox (CLX) has emerged as a sound investment opportunity supported by robust strategic initiatives, brand strength and 2020 Strategy.
Top Analyst Reports for Wal-Mart, Procter & Gamble and NVIDIA
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Wal-Mart (WMT), Procter & Gamble (PG) and NVIDIA (NVDA).
Procter & Gamble Appoints Peltz to Board After Proxy Battle
by Zacks Equity Research
Co-founder of Trian Fund Management, Nelson Peltz has been appointed to Procter & Gamble's (PG) board, effective Mar 1, 2018.
Procter & Gamble (PG) Tops Q1 Earnings & Revenues
by Zacks Equity Research
The Procter & Gamble Company (PG) reported core earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.07/share.
Should You Buy The Procter & Gamble (PG) Ahead of Earnings?
by Zacks Equity Research
The Procter & Gamble (PG) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Will Near-Term Challenges Mar Whirlpool's (WHR) Q3 Earnings?
by Zacks Equity Research
Whirlpool Corp. (WHR) is slated to release third-quarter 2017 results on Oct 23, after the closing bell. Last quarter, the company posted a negative earnings surprise of 6.9%.
Will V.F. Corp (VFC) Strategies Facilitate Q3 Earnings Beat?
by Zacks Equity Research
We expect the designer, manufacturer and marketer of branded apparel and related products, V. F. Corporation (VFC) to beat expectations when it reports third-quarter 2017 results on Oct 23.
Top Ranked Income Stocks to Buy for October 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 16th:
Is a Beat in the Cards for SUPERVALU (SVU) in Q2 Earnings?
by Zacks Equity Research
SUPERVALU (SVU) is likely to beat earnings estimates in second-quarter fiscal 2018. The company remains committed to its wholesale operations.
Top Stock Reports for Procter & Gamble, PetroChina & Biogen
by Zacks Equity Research
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), PetroChina (PTR) and Biogen (BIIB)
Top Stock Reports for Procter & Gamble, PetroChina & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), PetroChina (PTR) and Biogen (BIIB).
Will Colgate's Strategic Initiatives Help Counter Sales Woes?
by Zacks Equity Research
Colgate-Palmolive (CL) remains committed to its savings programs with a disciplined capital strategy. However, the company has a dismal sales trend.
In The Wake Of The Carnage
by Zacks Equity Research
In The Wake Of The Carnage
In The Wake Of The Carnage
by Zacks Equity Research
In The Wake Of The Carnage
Can Colgate's (CL) Strategies Regain the Stock Momentum?
by Zacks Equity Research
Colgate-Palmolive Company (CL) has been witnessing soft sales due to continued softness in North America and challenges in Asia-Pacific region. However, management remains on track to deliver growth.
Clorox's (CLX) Long-Term Strategy Bode Well: Here's Why
by Zacks Equity Research
The Clorox Company (CLX) remains keen on the smooth execution of its 2020 Strategy, which is aimed at boosting growth for the improvement of categories and overall market share.
Top Ranked Income Stocks to Buy for August 1st
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, August 1st: